Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Multiple Myeloma, Newly Diagnosed Clinical Trials

3 recruiting trials for Multiple Myeloma, Newly Diagnosed. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Recruiting Trials

RECRUITINGPhase 2 / Phase 3NCT06879379

KPD Consolidation After ASCT in NDMM Patients

This study aims to evaluate the efficacy and safety of post-transplant consolidation therapy with the KPD regimen (carfilzomib, pomalidomide, and dexamethasone) versus no...

Sponsor: Peking University People's HospitalEnrolling: 2023 locations
RECRUITINGPhase 2NCT06758375

Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients

This single-arm, open-label study aims to determine the efficacy and safety of low-dose, limited-duration teclistamab as a consolidation scheme in newly diagnosed multiple myeloma...

Sponsor: Hospital Universitario Dr. Jose E. GonzalezEnrolling: 101 location
RECRUITINGPhase 2NCT06974786

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided...

This is an open-label, multi-site, Phase II randomized trial with response-adaptive design for newly diagnosed multiple myeloma (NDMM) participants who have had prior induction...

Sponsor: SCRI Development Innovations, LLCEnrolling: 1009 locations